Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine

By Hagiwara Y.   Komase K.   Chen Z.   Matsuo K.   Suzuki Y.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2918-2926

Elsevier

Access to resources Recommend Favorite

A hepatitis B vaccine formulated with a novel adjuvant system

By Ambrosch F.   Wiedermann G.   Kundi M.   Leroux-Roels G.   Desombere I.   Garcon N.   Thiriart C.   Slaoui M.   Thoelen S.  

Vaccine, Vol. 18, Iss. 20, 2000-04 ,pp. : 2095-2101

Elsevier

Access to resources Recommend Favorite

A novel adjuvant for use with a blood-stage malaria vaccine

By de Souza J.B.   Playfair J.H.L.  

Vaccine, Vol. 13, Iss. 14, 1995-10 ,pp. : 1316-1319

Elsevier

Access to resources Recommend Favorite

Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity

By Patel Sapna   Faraj Yasser   Duso Debra K.   Reiley William W.   Karlsson Erik A.   Schultz-Cherry Stacey   Vajdy Michael  

Nutrients, Vol. 9, Iss. 5, 2017-05 ,pp. : 516-516

MDPI

Access to resources Recommend Favorite

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

By Thoelen S.   Van Damme P.   Mathei C.   Leroux-Roels G.   Desombere I.   Safary A.   Vandepapeliere P.   Slaoui M.   Meheus A.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 708-714

Elsevier

Access to resources Recommend Favorite